n-methyl-3,4-methylenedioxyamphetamine has been researched along with n-oleoylethanolamine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bermudez-Silva, FJ; Berrendero, F; De Fonseca, FR; Fernandez-Espejo, E; Maldonado, R; Parsons, LH; Pavon, FJ; Plaza-Zabala, A; Robledo, P; Serrano, A; Suarez, J | 1 |
1 other study(ies) available for n-methyl-3,4-methylenedioxyamphetamine and n-oleoylethanolamine
Article | Year |
---|---|
Effects of the endogenous PPAR-alpha agonist, oleoylethanolamide on MDMA-induced cognitive deficits in mice.
Topics: Animals; Avoidance Learning; Cognition Disorders; Corpus Striatum; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Endocannabinoids; Hallucinogens; Male; Mental Recall; Mesencephalon; Mice; N-Methyl-3,4-methylenedioxyamphetamine; Nootropic Agents; Oleic Acids; PPAR alpha; Rats; Rats, Wistar; Substantia Nigra; Treatment Outcome; Tyrosine 3-Monooxygenase | 2010 |